Skip to main content
. 2022 Sep 6;14(9):1882. doi: 10.3390/pharmaceutics14091882

Figure 2.

Figure 2

(AC) distribution of DBV Cmax after the first infusion, AUC0–1w, cumulative AUC0–4w, and DBV levels with regard to outcomes. Among all the PK parameters which were tested for their associations with treatment outcome, Cmax at the first dose, AUC0–1w, and cumulative AUC0–4w all resulted in higher values in cured patients, although these differences were not statistically significant.